Stella Cascioferro - Search Results

Year	Number of Results
2004	2
2006	1
2008	3
2009	3
2010	3
2011	2
2012	1
2013	1
2014	4
2015	5
2016	4
2017	9
2018	7
2019	9
2020	14
2021	2

1

Pharmacogenetics of treatments for pancreatic cancer.

El Hassouni B, Li Petri G, Liu DSK, Cascioferro S, Parrino B, Hassan W, Diana P, Ali A, Frampton AE, Giovannetti E. El Hassouni B, et al. Among authors: cascioferro s. Expert Opin Drug Metab Toxicol. 2019 Jun;15(6):437-447. doi: 10.1080/17425255.2019.1620731. Epub 2019 May 24. Expert Opin Drug Metab Toxicol. 2019. PMID: 31100206 Review.

2

Inhibitors of antibiotic resistance mechanisms: clinical applications and future perspectives.

Parrino B, Carbone D, Cirrincione G, Diana P, Cascioferro S. Parrino B, et al. Among authors: cascioferro s. Future Med Chem. 2020 Mar;12(5):357-359. doi: 10.4155/fmc-2019-0326. Epub 2020 Feb 6. Future Med Chem. 2020. PMID: 32027174 Free article. No abstract available.

3

Therapeutic Strategies To Counteract Antibiotic Resistance in MRSA Biofilm-Associated Infections.

Cascioferro S, Carbone D, Parrino B, Pecoraro C, Giovannetti E, Cirrincione G, Diana P. Cascioferro S, et al. ChemMedChem. 2021 Jan 8;16(1):65-80. doi: 10.1002/cmdc.202000677. Epub 2020 Nov 6. ChemMedChem. 2021. PMID: 33090669 Review.

4

New 1,2,4-Oxadiazole Nortopsentin Derivatives with Cytotoxic Activity.

Cascioferro S, Attanzio A, Di Sarno V, Musella S, Tesoriere L, Cirrincione G, Diana P, Parrino B. Cascioferro S, et al. Mar Drugs. 2019 Jan 8;17(1):35. doi: 10.3390/md17010035. Mar Drugs. 2019. PMID: 30626057 Free PMC article.

5

1,3,5-Triazines: A promising scaffold for anticancer drugs development.

Cascioferro S, Parrino B, Spanò V, Carbone A, Montalbano A, Barraja P, Diana P, Cirrincione G. Cascioferro S, et al. Eur J Med Chem. 2017 Dec 15;142:523-549. doi: 10.1016/j.ejmech.2017.09.035. Epub 2017 Oct 6. Eur J Med Chem. 2017. PMID: 29046238 Review.

6

2,6-Disubstituted imidazo[2,1-b][1,3,4]thiadiazole derivatives as potent staphylococcal biofilm inhibitors.

Cascioferro S, Parrino B, Petri GL, Cusimano MG, Schillaci D, Di Sarno V, Musella S, Giovannetti E, Cirrincione G, Diana P. Cascioferro S, et al. Eur J Med Chem. 2019 Apr 1;167:200-210. doi: 10.1016/j.ejmech.2019.02.007. Epub 2019 Feb 10. Eur J Med Chem. 2019. PMID: 30772604

7

Thiazoles, Their Benzofused Systems, and Thiazolidinone Derivatives: Versatile and Promising Tools to Combat Antibiotic Resistance.

Cascioferro S, Parrino B, Carbone D, Schillaci D, Giovannetti E, Cirrincione G, Diana P. Cascioferro S, et al. J Med Chem. 2020 Aug 13;63(15):7923-7956. doi: 10.1021/acs.jmedchem.9b01245. Epub 2020 Apr 2. J Med Chem. 2020. PMID: 32208685 Review.

8

Bacterial Biofilm Inhibition in the Development of Effective Anti-Virulence Strategy.

Parrino B, Diana P, Cirrincione G, Cascioferro S. Parrino B, et al. Among authors: cascioferro s. Open Med Chem J. 2018 Aug 31;12:84-87. doi: 10.2174/1874104501812010084. eCollection 2018. Open Med Chem J. 2018. PMID: 30288179 Free PMC article. No abstract available.

9

Antiadhesion agents against Gram-positive pathogens.

Cascioferro S, Cusimano MG, Schillaci D. Cascioferro S, et al. Future Microbiol. 2014;9(10):1209-20. doi: 10.2217/fmb.14.56. Future Microbiol. 2014. PMID: 25405889 Review.

10

Imidazo[2,1-b] [1,3,4]thiadiazoles with antiproliferative activity against primary and gemcitabine-resistant pancreatic cancer cells.

Cascioferro S, Petri GL, Parrino B, Carbone D, Funel N, Bergonzini C, Mantini G, Dekker H, Geerke D, Peters GJ, Cirrincione G, Giovannetti E, Diana P. Cascioferro S, et al. Eur J Med Chem. 2020 Mar 1;189:112088. doi: 10.1016/j.ejmech.2020.112088. Epub 2020 Jan 25. Eur J Med Chem. 2020. PMID: 32007666

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results